Vaccination in the Elderly and IBD
- 7 Downloads
Purpose of review
Significant gaps in knowledge and utilization of vaccinations exist among practitioners providing care for patients with IBD. This review is intended to update the reader on best practices for vaccination within the IBD population with a specific focus on the elderly.
Advances in IBD therapeutics have recently increased the number of immunosuppressive therapies available to practitioners. Differences in mechanisms of action of these medications have led to differential implications pertaining to vaccination strategies. Additionally, new vaccines, including the recombinant zoster vaccine, have recently become available for the use in the IBD population.
Given the prominent role the IBD provider plays in the management of patients with IBD, a clear understanding of best practices is essential. This review provides a framework for the integration of optimal vaccination strategies for practitioners caring for adult and elderly patients with IBD.
KeywordsInflammatory bowel disease Vaccination Preventive health maintenance Elderly Crohn’s disease Ulcerative colitis
Authored first draft (AC, DJL), critical revisions (all), approved final draft (all).
Compliance with Ethical Standards
Conflict of Interest
Dana Lukin reports grants and personal fees from Abbvie; personal fees from Janssen, Pfizer, Prometheus, Celgene, and Salix; and educational grants from Takeda. Anthony Choi declares that he has no conflict of interest. Preston Atteberry declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently are highlighted as follows: • Of importance •• Of major importance
- 5.• Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14(2):253–8 This study identified gaps in the receipt of routine preventive care, including vaccinations, within the IBD population.PubMedCrossRefPubMedCentralGoogle Scholar
- 10.• Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol. 2018;40:83–94 This article describes differnences in the immune response to vaccination among elderly patients.PubMedCrossRefPubMedCentralGoogle Scholar
- 13.• Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155(2):337–346.e10 Synopsis of infectious risk among patients with IBD. This frames the need for preventive vaccination in this population.Google Scholar
- 15.Adult Immunization Schedule by Vaccine and Age Group | CDC [Internet]. [cited 2019 19];Available from: https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html
- 18.http://www.immunize.org/askexperts/experts_hpv.asp. Accessed June 30, 2019.
- 19.•• Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–58 This important guideline details best practices for preventive care within the IBD patient population with an in-depth description of vaccine recommendations.PubMedCrossRefPubMedCentralGoogle Scholar
- 28.Reich JS, Miller HL, Wasan SK, et al. Influenza and pneumococcal vaccination rates in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(6):396–401.Google Scholar
- 35.• Pratt PK, David N, Weber HC, et al. Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy. Inflamm Bowel Dis. 2018;24(2):380–6 This recent study highlights the potential adverse impact of TNF antagonist therapy on the immunogenicity of the hepatitis B vaccine in the IBD population.PubMedCrossRefPubMedCentralGoogle Scholar
- 37.Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR-16):1–33 quiz CE1.Google Scholar
- 44.Lu Y, Bousvaros A. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (N Y). 2014;10(6):355–63.Google Scholar
- 50.• Melmed GY. Vaccinations while on thiopurines: some protection is better than none. Am J Gastroenterol. 2012;107(1):141–2 This study demonstrates that despite numerous studies demonstrating a blunted immune response to vaccinations among patients with IBD receiving thiopurine immunosuppression, the diminished immune response is still likely sufficient to provide protection against illness, including with influenza.PubMedCrossRefPubMedCentralGoogle Scholar
- 54.Nielsen HJ, Mortensen T, Holten-Andersen M, Brünner N, Sørensen S, Rask-Madsen J. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol. 2001;36(3):265–9.PubMedCrossRefPubMedCentralGoogle Scholar
- 56.Ekenberg C, Friis-Møller N, Ulstrup T, Aalykke C. Inadvertent yellow fever vaccination of a patient with Crohn’s disease treated with infliximab and methotrexate. BMJ Case Rep. 2016;2016.Google Scholar
- 59.• Khan N, Vallarino C, Lissoos T, Darr U, Luo M. Risk of infection and types of infection among elderly patients with inflammatory bowel disease: a retrospective database analysis. Inflamm Bowel Dis 2019. This large retrospective Truven database study identified an increased risk of pneumonia and sepsis among elderly patients with IBD as compared to those aged 18-64.Google Scholar
- 61.• Kantsø B, Simonsen J, Hoffmann S, Valentiner-Branth P, Petersen AM, Jess T. Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977-2013. Am J Gastroenterol. 2015;110(11):1582–7 This study highlights the increased risk of invasive pneumococcal infection within patients with IBD and therefore the importance of proactive immunization in the immunosuppressed population.PubMedCrossRefPubMedCentralGoogle Scholar
- 64.van Aalst M, Garrido HMG, van der Leun J, et al. Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease. Clin Infect Dis 2019;Google Scholar
- 81.• Wyant T, Leach T, Sankoh S, et al. Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results. Gut. 2015;64(1):77–83. Vedolizumab as a gut-selective lymphocyte trafficking inhibitor which does not cause systemic immunosuppression. This study shows that immunogenicity to oral antigens but not parenterally administered antigens is impaired by vedolizumab. The “gut-selectivity” leads to preserved systemic immune function, leading to the recommendation that live parenteral vaccines will not place patients at risk for infection.PubMedCrossRefPubMedCentralGoogle Scholar
- 82.UC A. ENTYVIO (vedolizumab) for injection, for intravenous use [Internet]. [cited 2019 28];Available from: https://www.accessdata.fda.gov/drugsaftda_docs/label/2014/125476s000lbl.pdf. Accessed June 30, 2019.
- 83.SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) Suspension for Intramuscular Injection [Internet]. [cited 2019 26];Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/shingrix. Accessed June 30, 2019.
- 84.• Reich J, Pei-Hsuan L, Zahorian T, Noronha A, Wasan SK, Farraye FA. P2231 - use of recombinant zoster vaccine (RZV-Shingrix) in patients with inflammatory bowel disease. ACG 2018 Annual Scientific Meeting Abastracts 2018 ;This is the first report of the use of the recombinant zoster vaccine among patients with IBD. While the size was limited, immunogenicity appears comparable with the general population.Google Scholar
- 88.IBD Checklist for Monitoring & Prevention [Internet]. [cited 2019 Apr 19];Available from: http://www.cornerstoneshealth.org/wp-content/uploads/2018/08/Monitoring-and-Prevention-8.31.18.pdf. Accessed June 30, 2019.
- 89.IBD and Keeping up with Immunization [Internet]. [cited 2019 18];Available from: https://www.crohnscolitisfoundation.org/assets/pdfs/factsheetimmunization.pdf. Accessed June 30, 2019.